It’s Time to Manage The Damage
Actinic Keratoses (AKs) are considered the earliest stage in skin cancer development.
They are common lesions of the outermost layer of the skin, caused by long-term exposure to sunlight.
[column width=”1/3″ title=”” title_type=”single” animation=”none” implicit=”true”]
[column width=”2/3″ last=”true” title=”” title_type=”single” animation=”none” implicit=”true”]
AKs are rough, scaly, red or brown patches that begin on the surface of the skin. They are mostly found among light-complectioned individuals — affecting over 50 percent of elderly fair-skinned persons in hot, sunny climates. They can also be found more rarely in individuals in their teens and twenties. Untreated, AKs may become malignant and should be treated.
The Levulan Kerastick is a unique therapeutic approach to manage Actinic Keratosis of the face or scalp. Levulan Kerastick is a topical solution that is applied to the AK. The solution is then absorbed by the AK cells where it is converted to a chemical that makes the cells extremely sensitive to light. The AK cells are exposed to a blue light irradiation using a special light source 14 to 18 hours after applying the solution. A reaction occurs under this light which destroys the AK cells.
The majority of the lesions treated in this way are completely cleared at 8 weeks with no scarring.
Other treatments for AKs include cryosurgery (freezing the skin), curettage (scraping), electrosurgery, excision, dermabrasion, laser surgery, and topical chemotherapy.
Request a consultation with Dr. Hynscht, MD to review your best options for treating AK.
Learn more about treatment